BIO-Europe Spring 2014: Interview with Mark Velleca, The Leukemia & Lymphoma Society

April 8, 2014
Mark Velleca of The Leukemia & Lymphoma Society (LLS) wants new therapies now for life threatening hematological disease. Mark talks about how the LLS is working hard to help support companies with promising treatments and accelerate their path to market. For more information on BIO-Europe Spring, visit our webpage: http://www.ebdgroup.com/bes/index.php Please view the rest of the video at http://www.partnering360.com/insight/showroom/id/499
Previous Video
BIO-Europe Spring 2014: Interview with Greg Scott, ChinaBio® LLC
BIO-Europe Spring 2014: Interview with Greg Scott, ChinaBio® LLC

ChinaBio® Partnering Forum 2014, to be held on May 7--8, 2014 in Suzhou, will attract biotech and pharma le...

Next Video
BIO-Europe Spring® 2014: Dealmaking strategies around orphan diseases
BIO-Europe Spring® 2014: Dealmaking strategies around orphan diseases

In recent years, orphan diseases have turned from ""do not touch"" to everyone's darling. With vast unmet m...